SCHEMBL14927077

SCHEMBL14927077

Cc1cc2cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)[nH]c(=O)c2cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 10/20 0.46
▸ GAA P10253 5/20 0.46
▸ ALDH1A1 P00352 4/20 0.43
▸ HPGD P15428 4/20 0.43
▸ PARP1 P09874 2/20 0.43
▸ CYP3A4 P08684 2/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ TNKS2 Q9H2K2 3/20 0.41
▸ TNKS O95271 3/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ ADORA2A P29274 1/20 0.40
▸ ADORA1 P30542 1/20 0.40
▸ MAPT P10636 3/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14927080 0.94 PARP1 (0.47) KDM4EGAAALDH1A1HPGDPARP1
SCHEMBL14927044 0.84 KMT2A (0.40) PARP1TNKS2TNKSCYP1A2ADORA2A
SCHEMBL12071547 0.81 PDE3B (0.48) KDM4EALDH1A1HPGDPOLBTNKS2
SCHEMBL16499568 0.77 PDE10A (0.47) KDM4EALDH1A1HPGDPARP1TNKS2
SCHEMBL9986595 0.77 PDE10A (0.47) KDM4EALDH1A1HPGDPARP1TNKS2
SCHEMBL30160749 0.75 KDM4E (0.59) KDM4EGAAALDH1A1HPGDPARP1
SCHEMBL28629567 0.75 KDM4E (0.59) KDM4EGAAALDH1A1HPGDPARP1
SCHEMBL31611876 0.73 TNKS (0.51) KDM4EALDH1A1HPGDPARP1TNKS2
SCHEMBL12070664 0.73 NQO2 (0.42) TNKS2TNKSNPC1RAB9A
SCHEMBL828493 0.72 TNKS (0.63) KDM4EGAAALDH1A1HPGDPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 KDM4E 2572/4885GAA 2760/4885ALDH1A1 3341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback